To help ensure adequate availability of veterinary drugs, the AVMA supports increased Congressional funding of the FDA Center for Veterinary Medicine for the NADA approval process indexed to keep pace with cost increases.
The AVMA supports user fees for new animal drug applications only if such fees are directed toward expediting the review and approval process for animal drug products.
* policy supersedes the policies "New Animal Drug Application (NADA) Approval Process" and "User Fees for Sponsors of New Animal Drug Applications"
Animal Drug User Fee Act Reauthorization
2017 American Veterinary Medical Association